{"infobox":{"dc_creator":"WooScraper_v1","dc_date_year":2024,"dc_identifier":"nl.oorg10123.2j.2024.47","dc_publisher":"oorg10123","dc_publisher_name":"Rijksinstituut voor Volksgezondheid en Milieu","dc_source":"https://www.rivm.nl/publicaties/effectiveness-of-xbb15-monovalent-covid-19-vaccines-during-period-of-xbb15-dominance-in","dc_title":"Effectiveness of XBB.1.5 Monovalent COVID-19 Vaccines During a Period of XBB.1.5 Dominance in EU/EEA Countries, October to November 2023: A VEBIS-EHR Network Study | RIVM","dc_type":"2j","dc_type_description":"2j - Onderzoek","foi_extraMetadata":{},"foi_files":[],"foi_isWoo":"Ja","foi_page_title":"Onderzoek Rijksinstituut voor Volksgezondheid en Milieu","foi_publishedDate":"2024-04-30","foi_retrievedDate":"2024-11-30","tooiwl_type":"c_fdaee95e"},"resource":"nl.oorg10123.2j.2024.47"}